Related Experiment Videos
Total synthesis of luminacin D
J Brad Shotwell1, Evan S Krygowski, John Hines
1Sterling Chemistry Laboratory, Department of Chemistry, Yale University, New Haven, Connecticut 06520, USA.
Organic Letters
|August 31, 2002
Summary
Researchers synthesized luminacin D, an angiogenesis inhibitor, using a novel samarium-iodide reaction. This efficient synthesis enables further studies into its mechanism of action.
Area of Science:
- Organic Synthesis
- Medicinal Chemistry
- Chemical Biology
Background:
- Angiogenesis is crucial for tumor growth, making inhibitors like luminacin D potential anti-cancer therapeutics.
- Developing efficient synthetic routes is essential for producing and studying complex natural products.
Purpose of the Study:
- To achieve a highly convergent synthesis of the angiogenesis inhibitor luminacin D.
- To develop a modular synthetic strategy amenable to derivatization for structure-activity relationship studies.
Main Methods:
- A samarium(II) iodide-mediated mixed tandem aldol/Evans-Tishchenko reaction was employed.
- The synthesis involved 13 linear steps and 19 total steps, achieving a 5.3% overall yield.
- The strategy focused on constructing the carbohydrate precursor efficiently.
Main Results:
- A highly convergent synthesis of luminacin D was successfully accomplished.
- The modular design facilitates modifications at critical positions.
- The overall yield was 5.3% over 19 steps.
Conclusions:
- The developed synthetic route provides a viable pathway to luminacin D.
- The modularity of the synthesis supports future biochemical investigations and drug development efforts.